2017
DOI: 10.1016/j.jcs.2017.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition study of red rice polyphenols on pancreatic α-amylase activity by kinetic analysis and molecular docking

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 51 publications
(21 citation statements)
references
References 28 publications
0
21
0
Order By: Relevance
“…Although orally administered OeB has some physical activity, this can be affected by many factors, including the extensive enzymatic and chemical modifications that occur during digestion and absorption (Scheepens, Tan, & Paxton, 2010). Previous studies have noted that most polyphenolic compounds from medicinal herbs can strongly interact with globular proteins, including digestive enzymes, which may reduce food digestibility (Han et al, 2008;Liu et al, 2017;Miao, Jiang, Jiang, Zhang, & Li, 2015;Rohn, And, & Kroll, 2002). As a macromolecular polyphenolic compound, OeB will inevitably interact with digestive tract enzymes in the body after oral administration, which may also influence the activity of digestive enzymes.…”
Section: Introductionmentioning
confidence: 99%
“…Although orally administered OeB has some physical activity, this can be affected by many factors, including the extensive enzymatic and chemical modifications that occur during digestion and absorption (Scheepens, Tan, & Paxton, 2010). Previous studies have noted that most polyphenolic compounds from medicinal herbs can strongly interact with globular proteins, including digestive enzymes, which may reduce food digestibility (Han et al, 2008;Liu et al, 2017;Miao, Jiang, Jiang, Zhang, & Li, 2015;Rohn, And, & Kroll, 2002). As a macromolecular polyphenolic compound, OeB will inevitably interact with digestive tract enzymes in the body after oral administration, which may also influence the activity of digestive enzymes.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, in silico analyses (also known as molecular modeling or docking) have been used as a relevant and unique tool to explain or predict dynamics and mechanisms of enzymatic inhibition, providing information about specific interactions and conformation of protein–inhibitor complexes at atomic level (Escobedo‐González et al., ; Liu et al., ; Zhou et al., ; Martínez Gonzalez, Alvarez‐Parrilla, et al., ; Chai et al., ). In this study, we performed molecular dockings for the three digestive enzymes: pancreatic α‐amylase, lipase, and trypsin and their binding with model PACs from C. illinoinensis .…”
Section: Introductionmentioning
confidence: 99%
“…Figure shows the molecular docking simulations (UCSF Chimera 1.12v software) of the interaction between the four model PACs and pancreatic α‐amylase, simulations with other enzymes showed similar behavior, although the interaction with α‐amylase presented the clearest tendency. Pancreatic α‐amylase is one of the α‐glucosidases recently recognized as therapeutic target for the prevention and control of diabetes mellitus type 2 (Liu et al., ); it hydrolyzes α‐1‐4 glycosidic linkages in starch, and its active site contains a catalytic triad formed by Asp 197 , Glu 233 , and Asp 300 . Figure shows that trimeric and tetrameric PACs bound with amino acid residues from this triad: kernel PACs (trimer and tetramer) bound with Asp 197 and Asp 300 (Figure A and B), while the shell tetramer interacted with Asp 300 and Glu 233 (Figure D).…”
Section: Introductionmentioning
confidence: 99%
“…The first one is due to the inhibitory action on mammal digestive enzymes such as α-amylase and α-glucosidase of various classes of camu-camu fruit extracts rich in polyphenolic compounds [22,25,72]. These bioactive compounds shown different inhibition mechanisms against these enzymes by binding to free enzyme and/or enzyme-substrate complexes, causing competitive inhibition, noncompetitive inhibition, and/or mixed-type inhibition [73][74][75][76]. The second one is a result of the inhibitory action on intestinal sugar transporters (i.e., SGLT1 and GLUT2), which was demonstrated in several studies [77][78][79][80][81][82].…”
Section: Hypoglycemiant and Antidiabetic Activitiesmentioning
confidence: 99%